FREE SHIPPING over $40
OVER 9000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Home / Equine Research Bank / Front Vet Sci / Effects of Production Method and Repeated Freeze Thaw Cycles...
Frontiers in veterinary science2021; 8; 759828; doi: 10.3389/fvets.2021.759828

Effects of Production Method and Repeated Freeze Thaw Cycles on Cytokine Concentrations and Microbial Contamination in Equine Autologous Conditioned Serum.

Abstract: Autologous conditioned serum (ACS) is a common intra-articular treatment for osteoarthritis in horses. The objective of this study was to investigate the influence of ACS preparation method on product contamination and concentrations of relevant cytokines and the influence of multiple freeze/thaw cycles. Blood was obtained from 10 healthy Thoroughbred horses and processed in parallel using a commercial and a non-commercial method to obtain ACS. Fluorescent microsphere immunoassay (FMIA) analysis was performed to quantify Interleukin 1 receptor antagonist (IL-1Ra), Interleukin-10 (IL-10), Interleukin-1β (IL-1β) and tumor necrosis factor-α (TNF-α) concentrations in ACS obtained by both production methods. Effect of 3, 4 and 5 freeze/thaw cycles on concentrations of IL-1Ra, IL-10, IL-1β and TNF-α were assessed against baseline samples (2 cycles) in commercial ACS products. Standard aerobic and anaerobic culture methods were applied to both ACS products. Mixed effect one-way analyses of variance (ANOVA) were used to compare the two ACS production method for each cytokine. Repeated measures, mixed effect ANOVA were used to assess the effect of freeze/thaw on cytokine concentrations. Significance was set at < 0.05. There was no difference in cytokine concentration between production methods (IL-1Ra = 0.067, IL-1β = 0.752, IL-10 = 0.211 and TNF-α = 0.25). Microbial growth was only observed in two samples obtained using the commercial production method. When compared to baseline, IL-1Ra concentration was decreased following the 5th freeze/thaw cycle ( < 0.001). These results suggest that the concentration of important cytokines are not influenced by ACS production method. When storing ACS samples for future use, freeze/thaw cycles associated with standard clinical practice are unlikely to influence cytokine concentrations. However, the lack of outcome measures associated with 1 or 2 freeze/thaw cycles represents a limitation of this study.
Copyright © 2021 Hale, Hughes, Hall and Labens.
Get Full Text
Publication Date: 2021-11-25 PubMed ID: 34901249PubMed Central: PMC8656450DOI: 10.3389/fvets.2021.759828Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research focused on the impact of various preparation methods and repeated freeze-thaw cycles on the concentration of certain cytokines and the chance of contamination in equine autologous conditioned serum (ACS). It revealed that all tested factors didn’t have any noteworthy influence on the levels of these cytokines (natural biochemical substances) and contamination only occurred in a couple of instances when a commercial production method was used.

Methodology of the Study

  • Blood was acquired from 10 healthy Thoroughbred horses and processed evenly using both a commercial and a non-commercial method to obtain ACS.
  • An analysis was then carried out using a Fluorescent Microsphere Immunoassay (FMIA) to measure the concentrations of certain types of cytokines: Interleukin 1 receptor antagonist (IL-1Ra), Interleukin-10 (IL-10), Interleukin-1β (IL-1β) and Tumor Necrosis Factor-α (TNF-α) in ACS obtained by both production methods.
  • The effect of 3, 4 and 5 freeze/thaw cycles on concentrations of those cytokines were also assessed against baseline samples (2 cycles) in ACS products produced commercially.
  • Standard aerobic and anaerobic culture methods were applied to both ACS products.
  • Mixed effect one-way analyses of variance (ANOVA) were used to compare the two ACS production methods for each cytokine, alongside repeated measures and mixed effect ANOVA to assess the effect of freeze/thaw on cytokine concentrations.

Results of the Study

  • No significant difference in cytokine concentration were found between different production methods, with the results for IL-1Ra, IL-1β, IL-10 and TNF-α showing no statistical significance.
  • Microbes were only found in two samples obtained through the commercial production method.
  • When compared to the baseline, only the IL-1Ra concentration was noticed to decrease after the 5th freeze/thaw cycle, indicating that frequent freeze-thaw processes might affect particular cytokines stability.
  • Consequently, the study concluded that the concentration of key cytokines was unaffected by the ACS production method used.

Implications and Limitations

  • Storing ACS samples for future use with freeze/thaw cycles usually involved in standard clinical practice is not expected to affect cytokine concentrations.
  • The study limitations include an absence of outcome measures related to 1 or 2 freeze/thaw cycles, suggesting that the research may not fully cover the potential effects of less repeated freeze/thaw cycles on cytokine stability or microbial growth in the sample.

Cite This Article

APA
Hale J, Hughes K, Hall S, Labens R. (2021). Effects of Production Method and Repeated Freeze Thaw Cycles on Cytokine Concentrations and Microbial Contamination in Equine Autologous Conditioned Serum. Front Vet Sci, 8, 759828. https://doi.org/10.3389/fvets.2021.759828

Publication

Frontiers in veterinary science
ISSN: 2297-1769
NlmUniqueID: 101666658
Country: Switzerland
Language: English
Volume: 8
Pages: 759828
PII: 759828

Researcher Affiliations

Hale, Josephine
  • School of Agricultural, Environmental and Veterinary Sciences, Charles Sturt University, Wagga Wagga, NSW, Australia.
Hughes, Kristopher
  • School of Agricultural, Environmental and Veterinary Sciences, Charles Sturt University, Wagga Wagga, NSW, Australia.
Hall, Sarah
  • Animal & Veterinary Sciences Department, Scotland's Rural College, Edinburgh, United Kingdom.
Labens, Raphael
  • School of Agricultural, Environmental and Veterinary Sciences, Charles Sturt University, Wagga Wagga, NSW, Australia.

Conflict of Interest Statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References

This article includes 39 references
  1. McIlwraith CW. Principles and practices of joint disease treatment. .
  2. Stacey L, Oke WM. Review of the economic impact of osteoarthrtitis and oral joint-health supplements in horses. AAEP Proc (2010) 56:12–6.
  3. Whitton RC, Jackson MA, Campbell AJ, Anderson GA, Parkin TD, Morton JM, Boden LA. Musculoskeletal injury rates in Thoroughbred racehorses following local corticosteroid injection.. Vet J 2014 Apr;200(1):71-6.
    doi: 10.1016/j.tvjl.2013.09.003pubmed: 24690214google scholar: lookup
  4. Frisbie DD, Kawcak CE, Baxter GM, Trotter GW, Powers BE, Lassen ED, McIlwraith CW. Effects of 6alpha-methylprednisolone acetate on an equine osteochondral fragment exercise model.. Am J Vet Res 1998 Dec;59(12):1619-28.
    pubmed: 9858417
  5. Bertone AL, Palmer JL, Jones J. Synovial fluid cytokines and eicosanoids as markers of joint disease in horses.. Vet Surg 2001 Nov-Dec;30(6):528-38.
    doi: 10.1053/jvet.2001.28430pubmed: 11704948google scholar: lookup
  6. Frisbie DD, McIlwraith CW, de Grauw JC. Synovial fluid and serum biomarkers. In: Trotter G. W. editors. Joint Disease in the Horse. 2nd Edition. Philadelphia, PA: W. B. Saunders, 179–91.
  7. Benito MJ, Veale DJ, FitzGerald O, van den Berg WB, Bresnihan B. Synovial tissue inflammation in early and late osteoarthritis.. Ann Rheum Dis 2005 Sep;64(9):1263-7.
    doi: 10.1136/ard.2004.025270pmc: PMC1755629pubmed: 15731292google scholar: lookup
  8. Meijer H, Reinecke J, Becker C, Tholen G, Wehling P. The production of anti-inflammatory cytokines in whole blood by physico-chemical induction.. Inflamm Res 2003 Oct;52(10):404-7.
    doi: 10.1007/s00011-003-1197-1pubmed: 14520515google scholar: lookup
  9. Frisbie DD, Ghivizzani SC, Robbins PD, Evans CH, McIlwraith CW. Treatment of experimental equine osteoarthritis by in vivo delivery of the equine interleukin-1 receptor antagonist gene.. Gene Ther 2002 Jan;9(1):12-20.
    doi: 10.1038/sj.gt.3301608pubmed: 11850718google scholar: lookup
  10. Frisbie DD, Kawcak CE, Werpy NM, Park RD, McIlwraith CW. Clinical, biochemical, and histologic effects of intra-articular administration of autologous conditioned serum in horses with experimentally induced osteoarthritis.. Am J Vet Res 2007 Mar;68(3):290-6.
    doi: 10.2460/ajvr.68.3.290pubmed: 17331019google scholar: lookup
  11. Textor J. Autologous biologic treatment for equine musculoskeletal injuries: platelet-rich plasma and IL-1 receptor antagonist protein.. Vet Clin North Am Equine Pract 2011 Aug;27(2):275-98.
    doi: 10.1016/j.cveq.2011.05.001pubmed: 21872759google scholar: lookup
  12. Arend WP, Malyak M, Guthridge CJ, Gabay C. Interleukin-1 receptor antagonist: role in biology.. Annu Rev Immunol 1998;16:27-55.
    doi: 10.1146/annurev.immunol.16.1.27pubmed: 9597123google scholar: lookup
  13. Rutgers M, Saris DB, Dhert WJ, Creemers LB. Cytokine profile of autologous conditioned serum for treatment of osteoarthritis, in vitro effects on cartilage metabolism and intra-articular levels after injection.. Arthritis Res Ther 2010;12(3):R114.
    doi: 10.1186/ar3050pmc: PMC2911907pubmed: 20537160google scholar: lookup
  14. Fjordbakk CT, Johansen GM, Løvås AC, Oppegård KL, Storset AK. Surgical stress influences cytokine content in autologous conditioned serum.. Equine Vet J 2015 Mar;47(2):212-7.
    doi: 10.1111/evj.12277pubmed: 24735323google scholar: lookup
  15. Lasarzik J, Bondzio A, Rettig M, Estrada R, Klaus C, Ehrle A. Evaluation of two protocols using autologous conditioned serum for intra-articular therapy of equine osteoarthritis—a pilot study monitoring cytokines and cartilage-specific biomarkers. J Equine Vet Sci (2018) 60:35–42.
    doi: 10.1016/j.jevs.2016.09.014google scholar: lookup
  16. Hall SA, Stucke D, Morrone B, Lebelt D, Zanella AJ. Simultaneous detection and quantification of six equine cytokines in plasma using a fluorescent microsphere immunoassay (FMIA).. MethodsX 2015;2:241-8.
    doi: 10.1016/j.mex.2015.04.002pmc: PMC4487921pubmed: 26150994google scholar: lookup
  17. Arend WP, Smith MF Jr, Janson RW, Joslin FG. IL-1 receptor antagonist and IL-1 beta production in human monocytes are regulated differently.. J Immunol 1991 Sep 1;147(5):1530-6.
    pubmed: 1831827
  18. Hraha TH, Doremus KM, McIlwraith CW, Frisbie DD. Autologous conditioned serum: the comparative cytokine profiles of two commercial methods (IRAP and IRAP II) using equine blood.. Equine Vet J 2011 Sep;43(5):516-21.
    doi: 10.1111/j.2042-3306.2010.00321.xpubmed: 21496084google scholar: lookup
  19. Magalon J, Bausset O, Veran J, Giraudo L, Serratrice N, Magalon G, Dignat-George F, Sabatier F. Physico-chemical factors influencing autologous conditioned serum purification.. Biores Open Access 2014 Feb 1;3(1):35-8.
    doi: 10.1089/biores.2013.0041pmc: PMC3929001pubmed: 24570844google scholar: lookup
  20. Lasarzik de Ascurra J, Ehrle A, Einspanier R, Lischer C. Influence of Incubation Time and Incubation Tube on the Cytokine and Growth Factor Concentrations of Autologous Conditioned Serum in Horses.. J Equine Vet Sci 2019 Apr;75:30-34.
    doi: 10.1016/j.jevs.2018.12.015pubmed: 31002089google scholar: lookup
  21. Arend WP, Welgus HG, Thompson RC, Eisenberg SP. Biological properties of recombinant human monocyte-derived interleukin 1 receptor antagonist.. J Clin Invest 1990 May;85(5):1694-7.
    doi: 10.1172/JCI114622pmc: PMC296623pubmed: 2139669google scholar: lookup
  22. Lasarzik J, Lischer CJ, Ehrle A, Estrada R, Rettig M, Klaus C. Interleukin-1 receptor antagonist and interleukin-1 beta levels in equine synovial fluid of normal and osteoarthritic joints: influence of anatomic joint location and repeated arthrocentesis. J Equine Vet Sci (2016) 42:67–72.
    doi: 10.1016/j.jevs.2016.03.017google scholar: lookup
  23. Baltzer AW, Moser C, Jansen SA, Krauspe R. Autologous conditioned serum (Orthokine) is an effective treatment for knee osteoarthritis.. Osteoarthritis Cartilage 2009 Feb;17(2):152-60.
    doi: 10.1016/j.joca.2008.06.014pubmed: 18674932google scholar: lookup
  24. Wehling P, Moser C, Frisbie D, McIlwraith CW, Kawcak CE, Krauspe R, Reinecke JA. Autologous conditioned serum in the treatment of orthopedic diseases: the orthokine therapy.. BioDrugs 2007;21(5):323-32.
    doi: 10.2165/00063030-200721050-00004pubmed: 17896838google scholar: lookup
  25. Marques-Smith P, Kallerud AS, Johansen GM, Boysen P, Jacobsen AM, Reitan KM, Henriksen MM, Löfgren M, Fjordbakk CT. Is clinical effect of autologous conditioned serum in spontaneously occurring equine articular lameness related to ACS cytokine profile?. BMC Vet Res 2020 Jun 8;16(1):181.
    doi: 10.1186/s12917-020-02391-7pmc: PMC7278142pubmed: 32513154google scholar: lookup
  26. Nixon AJ, Haupt JL, Frisbie DD, Morisset SS, McIlwraith CW, Robbins PD, Evans CH, Ghivizzani S. Gene-mediated restoration of cartilage matrix by combination insulin-like growth factor-I/interleukin-1 receptor antagonist therapy.. Gene Ther 2005 Jan;12(2):177-86.
    doi: 10.1038/sj.gt.3302396pubmed: 15578043google scholar: lookup
  27. Morisset S, Frisbie DD, Robbins PD, Nixon AJ, McIlwraith CW. IL-1ra/IGF-1 gene therapy modulates repair of microfractured chondral defects.. Clin Orthop Relat Res 2007 Sep;462:221-8.
    doi: 10.1097/BLO.0b013e3180dca05fpubmed: 17534189google scholar: lookup
  28. Hague BA, Honnas CM, Simpson RB, Peloso JG. Evaluation of skin bacterial flora before and after aseptic preparation of clipped and nonclipped arthrocentesis sites in horses.. Vet Surg 1997 Mar-Apr;26(2):121-5.
    doi: 10.1111/j.1532-950X.1997.tb01474.xpubmed: 9068162google scholar: lookup
  29. Chiller K, Selkin BA, Murakawa GJ. Skin microflora and bacterial infections of the skin.. J Investig Dermatol Symp Proc 2001 Dec;6(3):170-4.
    doi: 10.1046/j.0022-202x.2001.00043.xpubmed: 11924823google scholar: lookup
  30. Geraghty TE, Love S, Taylor DJ, Heller J, Mellor DJ, Hughes KJ. Assessing techniques for disinfecting sites for inserting intravenous catheters into the jugular veins of horses.. Vet Rec 2009 Jan 10;164(2):51-5.
    doi: 10.1136/vr.164.2.51pubmed: 19136685google scholar: lookup
  31. Gyles CL. Pathogenesis of Bacterial Infections in Animals. Iowa: Wiley-Blackwell; (2010).
  32. Simpson S, Kaislasuo J, Guller S, Pal L. Thermal stability of cytokines: A review.. Cytokine 2020 Jan;125:154829.
    doi: 10.1016/j.cyto.2019.154829pubmed: 31472404google scholar: lookup
  33. Graham C, Chooniedass R, Stefura WP, Lotoski L, Lopez P, Befus AD, Becker AB, HayGlass KT. Stability of pro- and anti-inflammatory immune biomarkers for human cohort studies.. J Transl Med 2017 Mar 2;15(1):53.
    doi: 10.1186/s12967-017-1154-3pmc: PMC5335797pubmed: 28253888google scholar: lookup
  34. Huang WY, Kemp TJ, Pfeiffer RM, Pinto LA, Hildesheim A, Purdue MP. Impact of freeze-thaw cycles on circulating inflammation marker measurements.. Cytokine 2017 Jul;95:113-117.
    doi: 10.1016/j.cyto.2017.02.016pmc: PMC6411278pubmed: 28260648google scholar: lookup
  35. Kenis G, Teunissen C, De Jongh R, Bosmans E, Steinbusch H, Maes M. Stability of interleukin 6, soluble interleukin 6 receptor, interleukin 10 and CC16 in human serum.. Cytokine 2002 Sep 7;19(5):228-35.
    doi: 10.1016/S1043-4666(02)91961-7pubmed: 12393169google scholar: lookup
  36. Kordulewska NK, Topa J, Tańska M, Cieślińska A, Fiedorowicz E, Jarmołowska B. Stability of interleukin-1β, -4, -6, -8, -10, -13, interferon-γ and tumor necrosis factor-α in human sera after repetitive freeze-thaw cycles and long storage.. J Pharm Biomed Anal 2021 Mar 20;196:113900.
    doi: 10.1016/j.jpba.2021.113900pubmed: 33535109google scholar: lookup
  37. Thavasu PW, Longhurst S, Joel SP, Slevin ML, Balkwill FR. Measuring cytokine levels in blood. Importance of anticoagulants, processing, and storage conditions.. J Immunol Methods 1992 Aug 30;153(1-2):115-24.
    doi: 10.1016/0022-1759(92)90313-Ipubmed: 1381403google scholar: lookup
  38. Aziz N, Nishanian P, Mitsuyasu R, Detels R, Fahey JL. Variables that affect assays for plasma cytokines and soluble activation markers.. Clin Diagn Lab Immunol 1999 Jan;6(1):89-95.
    doi: 10.1128/CDLI.6.1.89-95.1999pmc: PMC95666pubmed: 9874670google scholar: lookup
  39. de Jager W, Bourcier K, Rijkers GT, Prakken BJ, Seyfert-Margolis V. Prerequisites for cytokine measurements in clinical trials with multiplex immunoassays.. BMC Immunol 2009 Sep 28;10:52.
    doi: 10.1186/1471-2172-10-52pmc: PMC2761376pubmed: 19785746google scholar: lookup

Citations

This article has been cited 1 times.
  1. Bowlby CM, Purmessur D, Durgam SS. Equine peripheral blood CD14(+) monocyte-derived macrophage in-vitro characteristics after GM-CSF pretreatment and LPS+IFN-γ or IL-4+IL-10 differentiation.. Vet Immunol Immunopathol 2023 Jan;255:110534.
    doi: 10.1016/j.vetimm.2022.110534pubmed: 36502640google scholar: lookup
Subscribe to our newsletter
Join 99,357 horse owners like you who receive our email updates on horse health and nutrition.